## 3 Results
### Non-Targeted LC-QTOF-MS Based Metabolomics Data
 \\ \hline \multicolumn{7}{c}{_Organacygen compounds_} \\ \hline Trehalose & C\({}_{12}\)H\({}_{22}\)O\({}_{11}\) & 342.1162 & 1.13 & 0 & [M-H]\({}^{-}\) & ESI \(-\) & Level 2 & 0.93 \\ \hline Kobusone & C\({}_{14}\)H\({}_{22}\)O\({}_{2}\) & 222.1620 & 15.83 & 3 & [M-H]\({}^{-}\) & ESI \(-\) & Level 2 & 0.51 \\ \hline Methyl-pentenone & C\({}_{6}\)H\({}_{40}\)O & 98.0732 & 16.46 & 1 & [M-H-H\({}_{2}\)O]\({}^{-}\) & ESI \(-\) & Level 3 & 0.75 \\ \hline Methylpicraquasisoside A & C\({}_{19}\)H\({}_{24}\)O\({}_{10}\) & 412.1369 & 16.61 & 10 & [M+CI]\({}^{-}\) & ESI \(-\) & Level 3 & 0.68 \\ \hline (carboxymethoxy)-trihydroxy-carboxylate acid & C\({}_{8}\)H\({}_{22}\)O\({}_{9}\) & 252.0481 & 16.81 & 1 & [M+HCOOH-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.61 \\ \hline Epoxyprogesterone & C\({}_{21}\)H\({}_{28}\)O\({}_{3}\) & 328.2038 & 17.39 & 2 & [M-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.59 \\ \hline \multicolumn{7}{c}{_Phenylpropanoids_} \\ \hline Clausarinol & C\({}_{24}\)H\({}_{30}\)O\({}_{6}\) & 414.2042 & 14.59 & 4 & [M+H]\({}^{*}\) & ESI \(+\) & Level 3 & 4.45 \\ \hline
6-(l2-(dihydropyoxyphenyl)-3- (dimethylMeta-dien-yl)-hydroxy-(methylbut-2-en-yl)-d-oxo-4H-chromen-6-yloxyl-trihydroxyaxen-carboxylate acid & C\({}_{38}\)H\({}_{22}\)O\({}_{12}\) & 666.2676 & 15.58 & 1 & [M-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.33 \\ \hline Nevskin & C\({}_{24}\)H\({}_{22}\)O\({}_{9}\) & 400.2250 & 16.27 & 1 & [M+H]\({}^{*}\) & ESI \(+\) & Level 3 & 0.60 \\ \hline Methoxy-abietatrienolide & C\({}_{21}\)H\({}_{23}\)O\({}_{3}\) & 328.2038 & 16.48 & 1 & [M-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.47 \\ \hline Nordthyroguiaretic acid & C\({}_{18}\)H\({}_{22}\)O\({}_{4}\) & 302.1518 & 16.65 & 2 & [M-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.32 \\ \hline \multicolumn{7}{c}{_Piperidines_} \\ \hline Pipecritine & C\({}_{23}\)H\({}_{43}\)NO & 349.3345 & 15.91 & 5 & [M+H-H\({}_{2}\)O]\({}^{*}\) & ESI \(+\) & Level 3 & 4.88 \\ \hline \multicolumn{7}{c}{_Polybeptides_} \\ \hline Cannabididic acid & C\({}_{22}\)H\({}_{30}\)O\({}_{4}\) & 358.2144 & 16.26 & 4 & [M+H-H\({}_{2}\)O]\({}^{*}\) & ESI \(+\) & Level 3 & 7.15 \\ \hline Cannflavin A & C\({}_{26}\)H\({}_{20}\)O\({}_{6}\) & 436.1886 & 16.34 & 4 & [M+H]\({}^{*}\) & ESI \(+\) & Level 3 & 1.84 \\ \hline Betavulgarin & C\({}_{27}\)H\({}_{22}\)O\({}_{6}\) & 312.0634 & 16.34 & 3 & [M+H]\({}^{*}\) & ESI \(+\) & Level 3 & 1.18 \\ \hline Cannflavin A & C\({}_{26}\)H\({}_{20}\)O\({}_{6}\) & 436.1886 & 16.41 & 4 & [M+H]\({}^{*}\) & ESI \(-\) & Level 3 & 2.55 \\ \hline Chlorophorin & C\({}_{24}\)H\({}_{25}\)O\({}_{4}\) & 380.1988 & 16.46 & 8 & [M+HCOOH-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.53 \\ \hline Quercetol B & C\({}_{23}\)H\({}_{25}\)O\({}_{4}\) & 368.1988 & 16.51 & 3 & [M-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.67 \\ \hline \multicolumn{7}{c}{_Prenel lipids_} \\ \hline Icariside B8 & C\({}_{18}\)H\({}_{23}\)O\({}_{8}\) & 388.2097 & 6.19 & 2 & [M-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.34 \\ \hline Capsularone & C\({}_{27}\)H\({}_{38}\)O\({}_{8}\) & 490.2567 & 11.77 & 1 & [M+HCOOH-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.66 \\ \hline Diterpenoid EF-D & C\({}_{27}\)H\({}_{30}\)O\({}_{7}\) & 474.2618 & 13.60 & 1 & [M+HCOOH-H]\({}^{-}\) & ESI \(-\) & Level 3 & 1.13 \\ \hline Persicachrome & C\({}_{25}\)H\({}_{30}\)O\({}_{3}\) & 384.2664 & 14.33 & 4 & [M+H-H\({}_{2}\)O]\({}^{*}\) & ESI \(+\) & Level 3 & 0.72 \\ \hline Niggilic acid & C\({}_{15}\)H\({}_{20}\)O\({}_{5}\) & 280.1311 & 14.59 & 3 & [M+H]\({}^{*}\) & ESI \(+\) & Level 3 & 0.37 \\ \hline Yucelexin & C\({}_{20}\)H\({}_{20}\)O\({}_{4}\) & 330.1831 & 15.67 & 4 & [M-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.49 \\ \hline
2-(Hydroxy-methylphenyl)-5-methyl- 4- 4-hexen-3-one & C\({}_{14}\)H\({}_{15}\)O\({}_{2}\) & 218.1307 & 15.67 & 7 & [M-H]\({}^{-}\) & ESI \(-\) & Level 3 & 0.38 \\ \hline Tintinnnadiol & C\({}_{21}\)H\({}_{23}\)O\({}_{3}\) & 332.2351 & 15.76 & 1 & [M-H]\({}^{-}\) & ESI \(-\) & Level 3 & 1.21 \\ \hline Hydroxyymethylphenyl pentanone & C\({}_{21}\)H\({}_{40}\)O\({}_{2}\) & 192.1150 & 15.76 & 5 & [M+H]\({}^{*}\) & ESI \(+\) & Level 2 & 0.32 \\ \hline Dimethylrosmanol & C\({}_{22}\)H\({}_{30}\)O\({}_{5}\) & 374.2093 & 16.00 & 1 & [M-H]\({}^{-}\) & ESI \(-\) & Level 2 & 0.64 \\ \hline hydroxy-methoxy-(3-methylbut-2-en-1-yl)benzoic acid & C\({}_{13}\)H\({}_{16}\)O\({}_{4}  
Figure 7: Bar diagram with the number of compounds identified in _C.